Chemomab believes its existing liquidity resources as of June 30, 2024, together with the additional funds of approximately $10 million raised in July 2024, will enable the Company to fund its operations through the beginning of 2026.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMMB:
- Chemomab Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
- Chemomab Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update
- CMMB Earnings this Week: How Will it Perform?
- Chemomab Therapeutics Announces Closing of $10 Million Private Placement
- Chemomab Therapeutics price target raised to $9 from $7 at Roth MKM
Questions or Comments about the article? Write to editor@tipranks.com